A Systematic Review and Network Meta-Analysis on the Efficacy of Tumor Necrosis Factor Inhibitor-Methotrexate Combination Therapy Versus Triple Therapy in Methotrexate-Naive Patients with Rheumatoid Arthritis

被引:0
|
作者
Fleischmann, Roy [1 ]
Pope, Janet E. [2 ]
Tongbram, Vanita [3 ]
Tang, Derek [4 ]
Chung, James [4 ]
Collier, David [4 ]
Urs, Shilpa [3 ]
Ndirangu, Kerigo [3 ]
Wells, George A. [5 ]
van Vollenhoven, Ronald F. [6 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[2] Univ Western Ontario, London, ON, Canada
[3] ICON Plc, Morristown, NJ USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
[5] Univ Ottawa, Inst Heart, Cardiovasc Res Reference Ctr, Ottawa, ON, Canada
[6] Karolinska Inst, Dept Med, Unit Clin Therapy Res Inflammatory Dis ClinTRID, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1654
引用
收藏
页数:2
相关论文
共 50 条
  • [1] A Systematic Review and Network Meta-Analysis on the Efficacy of Tumor Necrosis Factor Inhibitor-Methotrexate Combination Therapy Versus Triple Therapy in Methotrexate Inadequate Responders with Rheumatoid Arthritis
    Fleischmann, Roy
    Pope, Janet E.
    Tongbram, Vanita
    Tang, Derek
    Chung, James
    Collier, David
    Urs, Shilpa
    Ndirangu, Kerigo
    Wells, George A.
    van Vollenhoven, Ronald F.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] PERSISTENCE AND ADHERENCE WITH TRIPLE THERAPY AND TUMOR NECROSIS FACTOR INHIBITOR-METHOTREXATE COMBINATION THERAPY IN US VETERANS WITH RHEUMATOID ARTHRITIS
    Cannon, G. W.
    Teng, C. C.
    Tang, D. H.
    Leng, J.
    Harrison, D. J.
    Sauer, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 460 - 461
  • [3] Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naive Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis
    Gulacsi, Laszlo
    Zrubka, Zsombor
    Brodszky, Valentin
    Rencz, Fanni
    Alten, Rieke
    Szekanecz, Zoltan
    Pentek, Marta
    ADVANCES IN THERAPY, 2019, 36 (03) : 721 - 745
  • [4] Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis
    Curtis, Jeffrey R.
    Palmer, J. Lynn
    Reed, George W.
    Greenberg, Jeffrey
    Pappas, Dimitrios A.
    Harrold, Leslie R.
    Kremer, Joel M.
    ARTHRITIS CARE & RESEARCH, 2021, 73 (08) : 1114 - 1124
  • [5] Perioperative Management of Methotrexate and Tumor Necrosis Factor Inhibitor Combination Therapy in Rheumatoid Arthritis Patients
    Juo, Hsin-Hsuan
    Ng, Bernard
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [6] Higher Persistence and Adherence with Combination Therapy with Tumor Necrosis Factor Inhibitor plus Methotrexate Combination Versus Triple Therapy in US Veterans with Rheumatoid Arthritis
    Sauer, Brian
    Teng, Chia-Chen
    Leng, Jianwei
    Mikuls, Ted R.
    Curtis, Jeffrey R.
    Stolshek, Bradley S.
    Tang, Derek
    Cannon, Grant W.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [7] Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis
    Sauer, Brian C.
    Teng, Chia-Chen
    Tang, Derek
    Leng, Jianwei
    Curtis, Jeffrey R.
    Mikuls, Ted R.
    Harrison, David J.
    Cannon, Grant W.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (03) : 313 - 322
  • [8] Methotrexate Monotherapy and Methotrexate Combination Therapy with Traditional and Biologic Dmards for Rheumatoid Arthritis: A Cochrane Systematic Review and Network Meta-Analysis
    Hazlewood, Glen S.
    Barnabe, Cheryl
    Tomlinson, George A.
    Marshall, Deborah
    Devoe, Daniel
    Bombardier, Claire
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [9] METHOTREXATE ASSOCIATED ADVERSE EVENTS AND THEIR PREDICTORS IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW
    Sherbini, A.
    Sharma, S.
    Gwinnutt, J.
    Hyrich, K.
    Verstappen, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1001 - 1002
  • [10] Induction maintenance with tumour necrosis factor-inhibitor combination therapy with discontinuation versus methotrexate monotherapy in early rheumatoid arthritis: a systematic review and meta-analysis of efficacy in randomised controlled trials
    Emamikia, Sharzad
    Arkema, Elizabeth V.
    Gyori, Noemi
    Detert, Jacqueline
    Chatzidionysiou, Katerina
    Dougados, Maxime
    Burmester, Gerd Ruediger
    van Vollenhoven, Ronald
    RMD OPEN, 2016, 2 (02):